We have 2 of 211 papers
We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.
Not the right person? Other researchers publish under this name.
Interim standards to guide healthcare professionals in the provision of variant-specific therapy for people with CF are produced, established using evidence from systematic reviews and expert opinion.
This review proposes RDA as a conceptual framework for identifying ongoing, potentially modifiable disease processes in people receiving CFTR modulators and considers the implications of RDA for clinical research by identifying key evidence gaps and outlining a stepwise pathway for its definition and validation.
We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.
